MRT Inc. (6034) AI Stock Analysis

• Market Cap: ¥3.89B
• Dividend Yield: N/A
• Average Volume (3M): 2.46K
• Price to Earnings (P/E): ―
• Beta (1Y): <0.01
• Revenue Growth: -7.73%
• EPS Growth: -303.99%
• Country: JP
• Employees: 304
• Sector: Healthcare
• Sector Strength: 39
• Industry: Medical - Healthcare Information Services
• EPS (TTM): -18.72
• Shares Outstanding: 5,718,600
• 10 Day Avg. Volume: 2,350
• 30 Day Avg. Volume: 2,463
• PEG Ratio: N/A
• Price to Book (P/B): 0.00
• Price to Sales (P/S): 0.00
• P/FCF Ratio: 0.00
• Enterprise Value/Market Cap: N/A
• Enterprise Value/Revenue: N/A
• Enterprise Value/Gross Profit: N/A
• Enterprise Value/Ebitda: N/A
• 1Y Price Target: ¥750.00
• Price Target Upside: 7.60% Upside
• Rating Consensus: Hold
• Number of Analyst Covering: 0

• Rating: 46 Neutral
• Price Target: ¥678.00 ▼(-2.73%Downside)

MRT Inc.'s overall stock score is primarily impacted by its financial performance and technical analysis. The company's financial health is challenged by negative net income and EBIT, despite a strong equity position. Technically, the stock is in a bearish trend with weak momentum indicators. Valuation concerns arise from a negative P/E ratio, reflecting current unprofitability. The absence of earnings call insights and corporate events further limits positive influences on the score.

MRT Inc. Business Overview & Revenue Model

Company Description

MRT Inc. (6034) is a Japanese company specializing in the healthcare and medical sectors. The company is primarily involved in providing medical information services and operates platforms that connect medical professionals with the healthcare industry. MRT Inc. facilitates efficient communication and information exchange among healthcare practitioners, institutions, and patients.

How the Company Makes Money

MRT Inc. generates revenue through its digital platforms that offer a range of services including job placement and recruitment services for medical professionals, advertising and promotional services for healthcare products, and subscription fees for access to specialized medical information. The company partners with healthcare institutions, medical device manufacturers, and pharmaceutical companies to create a robust ecosystem that supports its monetization strategies. Additional revenue streams may include consulting and support services tailored to the needs of healthcare providers.

MRT Inc. Financial Statement Overview

Summary

MRT Inc. faces significant financial challenges with negative EBIT and net income, impacting the income statement. Despite a strong equity position and low debt, a decrease in total assets and equity raises concerns. Positive cash flow from operations indicates some resilience, though volatility in cash flows and declining asset base pose risks.

Income Statement

MRT Inc. has faced significant challenges in its income statement over the recent periods. The TTM data shows negative EBIT and net income, indicating substantial operating losses. The gross profit margin remains relatively stable but is overshadowed by the declining revenue and profitability. The revenue has shown volatility, with a marked decrease from previous highs, and the net profit margin is negative, reflecting ongoing difficulties in achieving profit.

Balance Sheet

The balance sheet of MRT Inc. displays some positive aspects, such as a strong equity position and a low debt-to-equity ratio, indicating financial stability. The equity ratio is healthy, suggesting that the company has a solid asset base. However, the consistent decrease in total assets and stockholders' equity over recent periods could be cause for concern if the trend continues.

Cash Flow

Cash flow from operations is positive in TTM, reflecting some operational resilience despite challenges in profitability. The free cash flow has grown, indicating effective management of capital expenditures. However, the operating cash flow to net income ratio is skewed due to negative net income, and fluctuations in cash flow from financing and investing activities may impact future liquidity.

Breakdown	Dec 2024	Dec 2023	Dec 2022	Dec 2021	Dec 2020
Income Statement
Total Revenue	4.17B	5.41B	8.74B	4.47B	2.56B
Gross Profit	2.74B	3.27B	5.60B	3.55B	1.76B
EBITDA	139.00M	1.10B	3.16B	1.45B	420.18M
Net Income	-309.16M	517.00M	2.16B	774.49M	131.81M
Balance Sheet
Total Assets	6.75B	6.47B	8.16B	4.98B	3.31B
Cash, Cash Equivalents and Short-Term Investments	2.62B	3.78B	4.90B	1.03B	1.59B
Total Debt	1.05B	641.00M	875.86M	1.04B	1.11B
Total Liabilities	2.12B	1.76B	3.67B	2.69B	1.75B
Stockholders Equity	4.52B	4.58B	4.39B	2.22B	1.52B
Cash Flow
Free Cash Flow	462.00M	-208.00M	4.43B	-405.64M	183.97M
Operating Cash Flow	503.04M	-193.00M	4.51B	-298.89M	294.97M
Investing Cash Flow	-1.84B	-243.61M	-431.11M	-206.51M	-64.61M
Financing Cash Flow	161.77M	-669.19M	-203.98M	-67.49M	-397.41M

MRT Inc. Technical Analysis

• Technical Analysis Sentiment: Negative
• Last Price: 697.00
• 50DMA: Negative
• 100DMA: Negative
• 200DMA: Negative
• MACD: Negative
• RSI: Neutral
• STOCH: Neutral

Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For JP:6034, the sentiment is Negative. The current price of 697 is below the 20-day moving average (MA) of 705.30, below the 50-day MA of 726.74, and below the 200-day MA of 722.07, indicating a bearish trend. The MACD of -7.54 indicates Negative momentum. The RSI at 43.92 is Neutral, neither overbought nor oversold. The STOCH value of 34.85 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Negative sentiment for JP:6034.

MRT Inc. Peers Comparison

Name	Overall Rating	Market Cap	P/E Ratio	ROE	Dividend Yield	Revenue Growth	EPS Growth
3671	85 Outperform	¥7.79B	12.03		9.26%	16.07%	72.83%
6545	77 Outperform	¥3.73B	14.49		1.73%	4.08%	94.18%
Sector *	51 Neutral	$7.38B	0.34	-69.01%	2.37%	16.35%	0.39%
6034	46 Neutral	¥3.89B	―		―	-7.73%	-303.99%
3628	45 Neutral	¥6.85B	―		―	16.49%	-483.70%
4438	44 Neutral	¥2.98B	―		―	-4.68%	-62.31%
3902	43 Neutral	¥19.65B	4,465.71		1.26%	-7.98%	-181.00%